SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

Nature Cell Biology

Volumn 1, Issue 4, 1999, Pages 193-199

  Carrano, Andrea C ^a   Eytan, Esther ^b   Hershko, Avram ^b   Pagano, Michele ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ANTISENSE OLIGODEOXYNUCLEOTIDE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN;

ARTICLE; CELL LINE; DRUG ANTAGONISM; GENETICS; HELA CELL; HUMAN; IN VITRO STUDY; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PROTEIN BINDING;

BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HELA CELLS; HUMANS; KINETICS; MICROTUBULE-ASSOCIATED PROTEINS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN BINDING; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 0033176887     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/12013     Document Type: Article

References (48)

1. Sherr, C. & Roberts, J. Cdk inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1514 (1999).
2. Elledge, S. J., Winston, J. & Harper, J. W. A question of balance: the roles of cyclin kinase inhibitors in development and tumorigenesis. Trends Cell Biol. 6, 388-392 (1996).
3. Sheaff, R. I. & Roberts, J. M. in Cell Cycle Control, Results Probl. Cell Differ. Vol. 22 (ed. Pagano, M.) 1-34 (Springer, New York, 1998).
4. Hershko, A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell Biol. 9, 788-799 (1997).
5. Pagano, M. Regulation of cell cycle regulatory proteins by the ubiquitin pathway. FASEB J. 11, 1067-1075 (1997).
6. Patton, E., Willems, A. & Tyers, M. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 14, 6-14 (1998).
7. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive coforectal carcinomas. Nature Med. 3, 231-234 (1997).
8. Esposito, V. et al. Prognostic role of the cell cycle inhibitor p27 in non small cell lung cancer. Cancer Res. 57, 3381-3385 (1997).
9. Mayor, S. Protein marker linked with poor cancer outcome. Br. Med. J. 314, 323 (1997).
10. Steeg, P. & Abrams, J. Cancer prognostic: past, present and p27. Nature Med. 3, 152-154 (1997).
11. Ciechanover, A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17, 7151-7160 (1998).
12. Budel, L. et al. Characterization of p21, p27, p53 and E2F-1 cell cycle regulators in mantle cell lymphoma: increased ubiquitin-proteasome mediated degradation of p27. Blood (in the press).
13. Piva, R. et al. Increased proteasome-dependent degradation of p27 in malignant gliomas. J. Neuropathol. Exp. Neurol. (in the press).
14. Pagano, M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685 (1995).
15. Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181-1189 (1999).
16. Shirane, M. et al. Down-regulation of p27 by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol Chem. 274, 13886-13893 (1999).
17. Muller, D. et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15, 2561-2576 (1997).
18. Sheaff, R., Groudine, M., Gordon, M., Roberts, J. & Clurman, B. Cyclin E-Cdk2 is a regulator of p27Kip1. Genes Dev. 11, 1464-1478 (1997).
19. Vlach, J., Hennecke, S. & Amati, B. Phosphorylation-dependent of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J. 16, 5334-5344 (1997).
20. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
21. Koepp, D., Harper, J. W. & Elledge, S. J. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97, 431-433 (1999).
22. Latres, E., Chiaur, D. S. & Pagano, M. The human F-box protein β-Trcp associates with the Cull/ Skp1 complex and regulates the stability of β-catenin. Oncogene 18, 849-855 (1999).
23. Winston, J. T. et al. The SCFβ-TRCP ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
24. Laney, J. & Hochstrasser, M. Substrates targeting in the system. Cell 97, 427-430 (1999).
25. Zhang, H., Kobayashi, R., Galaktionov, K. & Beach, D. p19Skp-1 and p45Skp-2 are essential elements of the cyclin A-Cdk2 S phase kinase. Cell 82, 915-925 (1995).
26. Yaron, A. et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 396, 590-594 (1998).
27. Lisztwan, J. et al. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17, 368-383 (1998).
28. Michel, J. J. & Xiong, Y. Human Cul1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ. 9, 435-449 (1998).
29. Hart, M. et al. The F-box protein β-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 9, 207-210 (1999).
30. Spencer, E., Jiang, J. & Chen, Z. J. Signal-induced ubiquitination of IB by the F-box protein Slimb/β-TrCP. Genes Dev. 13, 284-294 (1999).
31. Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/Cullin catalyzes ubiquitination of the phosphorylated Cdk inhibitor Sic1p. Cell 91, 221-230 (1997).
32. Kominami, K. & Toda, T. Fission yeast WD-repeat protein pop1 regulates genome ploidy through ubiquitin-proteasome-mediated degradation of the CDK inhibitor Ruml and the S-phase initiator Cdc18. Genes Dev. 11, 1548-1560 (1997).
33. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209-219 (1997).
34. Kominami, K., Ochotorena, I. & Toda, T. Two F-box/WD-repeat proteins Pop1 and Pop2 form hetero- and homo-complexes together with cullin-1 in the fission yeast SCF (Skp1-Cullin1-F-box) ubiquitin ligase. Genes Cells 3, 721-735 (1998).
35. Jallepalli, P. V., Tien, D. & Kelly, T. J. sud1(+) targets cyclin-dependent kinase-phosphorylated Cdc18 and Rum1 proteins for degradation and stops unwanted diploidization in fission yeast. Proc. Natl Acad. Sci. USA 95, 8159-8164 (1998).
36. Maekawa, H., Kitamura, K. & Shimoda, C. The Ste16 WD-repeat protein regulates cell-cycle progression under starvation through the Rum1 protein in Schizosaccharomyces pombe. Curr. Genet. 33, 29-37 (1998).
37. Tomoda, K., Kubota, Y. & Kato, J. Degradation of the cyclin-dependent-kinase inhibitor p27 is instigated by Jab1. Nature 398, 160-164 (1999).
38. Yu, Z. K., Gervais, J. & Zhang, H. Human Cul1 associates with the Skp1/Skp2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl Acad. Sci. USA 95, 11324-11329 (1998).
39. Marti, A., Wirbelauer, C., Scheffner, M. & Krek, W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nature Cell Biol. 1, 14-19 (1999).
40. Pagano, M. et al. Regulation of the human cell cycle by the Cdk2 protein kinase. J. Cell Biol. 121, 101-111 (1993).
41. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W. & Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 761-771 (1992).
42. O'Connor, P. & Jackman, J. in Cell Cycle: Materials and Methods (ed. Pagano, M.) 63-74 (Springer, New York, 1995).
43. Pagano, M. in Cell Cycle: Materials and Methods (ed. Pagano, M.) 271-280 (Springer, New York, 1995).
44. Harlow, E. & Lane, D. in Using Antibodies. A Laboratory Manual (eds Harlow, E. & Lane, D.) 187-233 (Cold Spring Harb. Lab. Press, Cold Spring Harbor, 1998).
45. Faha, B., Harlow, E. & Lees, E. The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and Cyclin A-p33cdk2. J. Virol. 67, 2456-2465 (1993).
46. Pagano, M., Draetta, G. & Jansen-Dürr, P. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255, 1144-1147 (1992).
47. Desai, D., Gu, Y. & Morgan, D. O. Activation of human cyclin-dependent kinase in vitro. Mol. Biol. Cell 3, 571-582 (1992).
48. Hochstrasser, M. There's the rub: a novel ubiquitin-like modification linked to cell cycle regulation. Genes Dev. 12, 901-907 (1998).